Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Sep 16;103(5):1983–1985. doi: 10.4269/ajtmh.20-0678

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The American Society of Tropical Medicine and Hygiene

This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

PMC Copyright notice

Figure 2. — Time line of disease course and treatments from March 9, 2020 (day −21) to May 8, 2020 (day 39). Two courses of favipiravir (day 1: 1,800 mg twice daily and days 2–14: 800 mg twice daily), hydroxychloroquine (day 1: 400 mg twice daily and days 2–10: 200 mg twice daily), and inhaled ciclesonide (days 1–14: 400 μg twice daily). Polyglobin, 5 g, was administered for 3 days as intravenous immune globulin (IVIG) therapy. BR = bendamustine/rituximab.